【摘 要】
:
Objective: This study aimed to determine whether dietary fat intake increased liver cancer risk in Chinese women from a prospective population-based cohort. Methods: A total of 72,704 Chinese women were followed up from the time of baseline recruitment (1
【机 构】
:
State Key Laboratory of Oncogene and Related Genes&Department of Epidemiology,Shanghai Cancer Instit
论文部分内容阅读
Objective: This study aimed to determine whether dietary fat intake increased liver cancer risk in Chinese women from a prospective population-based cohort. Methods: A total of 72,704 Chinese women were followed up from the time of baseline recruitment (1996-2000) to the end of 2016. Dietary fat intake was calculated using a validated food frequency questionnaire. The Cox regression model was used to assess the hazard ratio (HR) and 95% confidence intervals (CI) for dietary fat intake and liver cancer risk. Results: We identified 252 incident liver cancer cases out of 1,267,845 person-years during the overall follow-up time. Null associations, neither in quartiles nor per standard deviation (SD) increment, were detected between liver cancer risk and dietary total fat, fat subtypes and subtype ratios, and food sources. The HR (95% CI) of the 1-SD increment was 1.03 (0.90-1.17) for total fat, 1.06 (0.93-1.20) for saturated fat, 1.06 (0.93-1.21) for monounsaturated fat, and 1.00 (0.89-1.13) for polyunsaturated fat. Similar null associations were observed in stratification analyses according to body mass index and menopausal status. Conclusions: In our prospective cohort study, no significant association was observed in Chinese women between dietary fat and liver cancer risk, and in stratification and sensitivity analyses.
其他文献
Cytokine release syndrome (CRS) is a major obstacle to the widespread clinical application of chimeric antigen receptor (CAR) T cell therapies. CRS can also be induced by infections (such as SARS-CoV-2), drugs (such as therapeutic antibodies), and some au
Cancer metastasis remains one of the most confounding questions in oncology1,2. Although current cutting-edge techniques enable very early detection of tumors, profiling whether a tumor has already begun to spread and where it has attempted to colonize re
IntroductionrnCircular RNAs (circRNAs) are generated by the non-canonical back-splicing of pre-mRNA and have been shown to be present in a wide variety of tissues at lower expression levels than their asso-ciated linear RNAs1. The advent of high-throughpu
Proteins are key players in various cellular processes. As the ultimate executors of cellular processes, they play essen-tial roles in linking genotypes to phenotypes. Abnormalities in protein expression and post-translational modifications (PTMs) are clo
目的:调研老年高血压患者健康管理软件使用现状及需求,为相关平台优化提供参考.方法:对北京市3家基层社区的老年高血压患者进行线下问卷调研.结果:共回收219份有效问卷,男女比例为1∶1.64,年龄(69.73±7.38)岁.药物相互作用和不能接收专业的用药科普是老年高血压患者认为自身管理时最大的问题(46.6%),调研的人中有209人(95.4%)认为慢病日常管理重要,210人(95.9%)非常愿意使用健康管理类软件,203人(92.7%)认为慢病管理软件中应该有医生的参与,180人(82.2%)认为应该有
目的:探索医院药学服务障碍测量工具的优化策略与发展方向,以期提升我国药学服务障碍相关研究的质量.方法:以“医院”“医疗机构”“药学服务”“障碍”“阻碍”“限制”“Hospital”“Pharmaceutical Care”“Pharmacy Service”“Pharmaceuti-cal Service”“Barrier”“Obstacle”为中、英文关键词,组合检索中国知网、万方、维普、Medline、ScienceDirect数据库自建库至2021年4月1日发表的文献,从测量工具的开发背景、适用对象
目的 观察毫火针治疗肺胃热盛型急性咽炎的临床疗效.方法 将90例肺胃热盛型急性咽炎患者随机分为毫火针组、开喉剑喷雾剂组与联合组(毫火针联合开喉剑喷雾剂)各30例.分别在治疗前后统计每组症状体征评分表、主诉症状的临床改善时间以及肿瘤坏死因子-α(TNF-α)、C反应蛋白(CRP)、白细胞介素-1β(IL-1β)、白细胞介素-6(IL-6)水平.结果 症状体征评分结果表明,治疗后各组评分均降低,联合组均低于其他两组,同时毫火针组低于开喉剑喷雾剂组(P<0.05);联合组临床症状消失时间短于其余两组(P<0.0
目的 探讨血脂、血尿酸水平与青年急性脑梗死的相关性,并分析其与不同中医证型的关系及特点.方法 选取急性脑梗死的青年患者150例为观察组,随机纳入同期住院的非脑血管疾病患者150例为对照组.分析血脂、血尿酸与青年急性脑梗死相关性,探讨其在不同中医证型中的特点.结果 150例青年急性脑梗死患者血清指标中,甘油三酯、载脂蛋白B、脂蛋白a、尿酸均高于对照组,载脂蛋白A Ⅰ、高密度脂蛋白低于对照组,差异有统计学意义(P<0.05).经Logistic回归分析后,脂蛋白a和尿酸是青年发生急性脑梗死的独立危险因素(OR
Objective: Investigation of the regulatory mechanisms of cell stemness in cholangiocarcinoma (CCA) is essential for developing effective therapies to improve patient outcomes. The purpose of this study was to investigate the function and regulatory mechan
Objective: The mainstay treatment of esophageal squamous cell carcinoma (ESCC) involves chemotherapy and immunotherapy. However, alternative therapies are required for patients who are refractory or intolerant to existing therapies. Methods: In this singl